Sign inJoin waitlistJoin the waitlist

John Magenau

Medical Director, Adult Bone Marrow Transplant · University of Michigan

Credentials: · · ·

History

Adult Bone Marrow Transplant · University of Michigan
Present
University of Michigan
Present

University of Michigan
2008–2010
University of Michigan Health
2007–2008
Internal Medicine
University of Illinois College of Medicine at Chicago
2004–2007
Lewis Katz School of Medicine at Temple University
2000–2004

Research

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2019 · 3,379 citations
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
The Lancet Haematology · 2015 · 263 citations
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nature Medicine · 2018 · 251 citations

PR
Pavan Reddy
28 papers
AP
Attaphol Pawarode
25 papers
GY
Gregory Yanik
20 papers
MR
Mary Riwes
18 papers
John Levine
14 papers
Carrie Kitko
13 papers
Daniel Couriel
13 papers
MG
Monalisa Ghosh
10 papers
SA
Sarah Anand
10 papers
Brian Parkin
9 papers
AH
Andrew Harris
8 papers
James Ferrara
8 papers

Grants

Targeting Antigen Cross-Presentation to Enhance Anti-Leukemic Responses After Allogeneic Transplantation
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $982.8K · University of Michigan at Ann Arbor
2017–2021

Clinical trials

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
Principal investigator · Not yet recruiting · Phase 1
University of Michigan Rogel Cancer Center
2026–2029
Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
Principal investigator · Terminated · Phase 1
University of Michigan Rogel Cancer Center
2017–2021
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1, Phase 2
University of Michigan Rogel Cancer Center
2015–2019
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Principal investigator · Completed · Phase 2
University of Michigan Rogel Cancer Center
2011–2016